Dr. Martens Plc Statistics
Want to see GB:DOCS full AI Analyst Report?
Dr. Martens Plc (DOCS) Stock Statistics & Valuation Metrics
Total Valuation
Dr. Martens Plc has a market cap or net worth of GBX 518.03M. The enterprise value is GBX 952.18M.
- Market Cap
- GBX 518.03M
- Enterprise Value
- GBX 952.18M
Share Statistics
Dr. Martens Plc has 968,121,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 968,121,300
- Owned by Insiders
- 0.20%
- Owned by Institutions
- 13.40%
Financial Efficiency
Dr. Martens Plc’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 7.00%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 7.00%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 321.79K
- Profits Per Employee
- 10.01K
- Employee Count
- 2,377
- Asset Turnover
- 0.87
- Inventory Turnover
- 1.61
Valuation Ratios
The current PE Ratio of Dr. Martens Plc is 18.79. Dr. Martens Plc’s PEG ratio is 0.23.
- PE Ratio
- 18.79
- PS Ratio
- 0.71
- PB Ratio
- 1.57
- Price to FCF
- 5.61
- Price to Operating Cash Flow
- 5.02
- PEG Ratio
- 0.23
Income Statement
In the last 12 months, Dr. Martens Plc had revenue of 764.90M and earned 23.80M in profits. Earnings per share was 0.02.
- Revenue
- 764.90M
- Gross Profit
- 506.00M
- Operating Income
- 73.40M
- Pretax Income
- 32.70M
- Net Income
- 23.80M
- EBITDA
- 142.10M
- Earnings Per Share (EPS)
- 0.02
Cash Flow
In the last 12 months, operating cash flow was 103.20M and capital expenditures -10.90M, giving a free cash flow of 92.30M billion.
- Operating Cash Flow
- 103.20M
- Free Cash Flow
- 92.30M
- Free Cash Flow per Share
- 0.10
Dividends & Yields
Dr. Martens Plc pays an annual dividend of GBX 1.70, resulting in a dividend yield of 4.68%
- Dividend Per Share
- GBX 1.70
- Dividend Yield
- 4.68%
- Payout Ratio
- 77.27%
- Free Cash Flow Yield
- 17.82%
- Earnings Yield
- 5.37%
Stock Price Statistics
- Beta
- 1.39
- 52-Week Price Change
- -33.21%
- 50-Day Moving Average
- 65.67
- 200-Day Moving Average
- 68.05
- Relative Strength Index (RSI)
- 29.68
- Average Volume (3m)
- 1.63M
Important Dates
Dr. Martens Plc upcoming earnings date is Jun 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Jun 03, 2027
- Ex-Dividend Date
- Aug 27, 2026
Financial Position
Dr. Martens Plc as a current ratio of 2.61, with Debt / Equity ratio of 108.85%
- Current Ratio
- 2.61
- Quick Ratio
- 1.60
- Debt to Market Cap
- 0.41
- Net Debt to EBITDA
- 1.50
- Interest Coverage Ratio
- 2.65
Taxes
In the past 12 months, Dr. Martens Plc has paid 8.90M in taxes.
- Income Tax
- 8.90M
- Effective Tax Rate
- 0.27
Enterprise Valuation
Dr. Martens Plc EV to EBITDA ratio is 6.03, with an EV/FCF ratio of 8.97.
- EV to Sales
- 1.13
- EV to EBITDA
- 6.03
- EV to Free Cash Flow
- 8.97
- EV to Operating Cash Flow
- 8.02
Balance Sheet
Dr. Martens Plc has GBX 91.10M in cash and marketable securities with GBX 400.90M in debt, giving a net cash position of -GBX 309.80M billion.
- Cash & Marketable Securities
- GBX 91.10M
- Total Debt
- GBX 400.90M
- Net Cash
- -GBX 309.80M
- Net Cash Per Share
- -GBX 0.32
- Tangible Book Value Per Share
- GBX 0.06
Margins
Gross margin is 56.93%, with operating margin of 9.45%, and net profit margin of 3.79%.
- Gross Margin
- 56.93%
- Operating Margin
- 9.45%
- Pretax Margin
- 4.80%
- Net Profit Margin
- 3.79%
- EBITDA Margin
- 18.71%
- EBIT Margin
- 9.45%
Analyst Forecast
The average price target for Dr. Martens Plc is GBX 71.40, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- GBX 71.40
- Price Target Upside
- 31.01% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 5
- Revenue Growth Forecast
- -6.59%
- EPS Growth Forecast
- 79.38%
Scores
- Smart Score
- 1
- AI Score
- 54

